Bruno Trimarco

Summary

Affiliation: Federico II University
Country: Italy

Publications

  1. pmc Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes
    Natalia V Rivera
    IRCCS Multimedica, via Fantoli 16 15, 20138, Milan, Italy
    BMC Med Genet 14:11. 2013
  2. doi request reprint Omega-3 in antiarrhythmic therapy : pros position
    Bruno Trimarco
    Department of Internal Medicine and Cardiovascular Sciences, Federico II University, Via Sergio Pansini 5, Naples, 80131, Italy
    High Blood Press Cardiovasc Prev 19:201-5. 2012
  3. pmc A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity
    Daniela Sorriento
    Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Universita Federico II, Napoli, Italia
    Mol Cancer 8:97. 2009
  4. pmc In vivo properties of the proangiogenic peptide QK
    Gaetano Santulli
    Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Cattedra di Medicina Interna, Università degli Studi Federico II di Napoli, Italy
    J Transl Med 7:41. 2009
  5. pmc Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
    Gaetano Santulli
    Department of Clinical Medicine, Cardiovascular and Immunologic Sciences, Federico II University of Naples, Italy
    J Transl Med 9:7. 2011
  6. pmc The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
    Gennaro Galasso
    Department of Clinical Medicine, Cardiovascular and Immunologic Sciences, Federico II University School of Medicine, Naples, Italy
    BMC Cardiovasc Disord 10:41. 2010

Collaborators

  • Gaetano Santulli
  • Guido Iaccarino
  • Gennaro Galasso
  • Daniela Sorriento
  • Natalia V Rivera
  • Valentina Trimarco
  • Carlo Pedone
  • Federico Piscione
  • Alfonso Campanile
  • Petra Hoppmann
  • Najaf Amin
  • Gianluigi Condorelli
  • Lennart C Karssen
  • Gerolama Condorelli
  • Paolo Pagnotta
  • Raffaele Izzo
  • Robert Roberts
  • Cornelia M van Duijn
  • Adnan Kastrati
  • Li Chen
  • Carlo Briguori
  • Roberta Roncarati
  • Chiara Viviani-Anselmi
  • Robert Carreras-Torres
  • Annibale A Puca
  • Alexandre F R Stewart
  • Alessandra Mezzelani
  • Werner Koch
  • Francesca De Micco
  • Flavio Airoldi
  • Maria Felicia Basilicata
  • Laura Zaccaro
  • Annarita Del Gatto
  • Carmine Del Giudice
  • Michele Saviano
  • Mariarosaria De Simone
  • Antonio Anastasio
  • Massimo Chiariello
  • Raffaele Piccolo
  • Salvatore Cassese
  • Roberta De Rosa
  • Eleonora Leggiero
  • Giovanna Giuseppina Altobelli
  • Vincenzo Cimini
  • Luca Domenico D'Andrea
  • Michele Ciccarelli
  • Gianluigi Palumbo
  • Lucio Pastore
  • Barbara Ziaco

Detail Information

Publications6

  1. pmc Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes
    Natalia V Rivera
    IRCCS Multimedica, via Fantoli 16 15, 20138, Milan, Italy
    BMC Med Genet 14:11. 2013
    ..We investigated the association of 9p21.3 variants with severity of CAD (defined by the number of vessel diseased [VD]) in the presence and absence of T2D...
  2. doi request reprint Omega-3 in antiarrhythmic therapy : pros position
    Bruno Trimarco
    Department of Internal Medicine and Cardiovascular Sciences, Federico II University, Via Sergio Pansini 5, Naples, 80131, Italy
    High Blood Press Cardiovasc Prev 19:201-5. 2012
    ..Keeping these last points in mind, the answer to the previous question is a loud 'NO', also taking into account the fact that omega-3, in contrast to the other antiarrhythmics, do not negatively affect myocardial contractility...
  3. pmc A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity
    Daniela Sorriento
    Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Universita Federico II, Napoli, Italia
    Mol Cancer 8:97. 2009
    ..We recently demonstrated that the RH domain of GRK5 (GRK5-RH) inhibits NFkappaB, thus we evaluated its effects on cancer growth...
  4. pmc In vivo properties of the proangiogenic peptide QK
    Gaetano Santulli
    Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Cattedra di Medicina Interna, Università degli Studi Federico II di Napoli, Italy
    J Transl Med 7:41. 2009
    ..These data open to new fields of investigation on the mechanisms of activation of VEGF receptors, offering clinical implications for treatment of pathophysiological conditions such as chronic ischemia...
  5. pmc Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
    Gaetano Santulli
    Department of Clinical Medicine, Cardiovascular and Immunologic Sciences, Federico II University of Naples, Italy
    J Transl Med 9:7. 2011
    ..We have recently synthesized a new and selective ligand of αVβ3 receptor, referred to as RGDechiHCit, that contains a cyclic RGD motif and two echistatin moieties...
  6. pmc The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
    Gennaro Galasso
    Department of Clinical Medicine, Cardiovascular and Immunologic Sciences, Federico II University School of Medicine, Naples, Italy
    BMC Cardiovasc Disord 10:41. 2010
    ..We aimed to explore the effect of PlA2 polymorphism on outcome in patients with atherosclerosis...